Abstract:Objective To explore the prevalence of SLC25A13 gene mutations in Chinese infants with intrahepatic cholestasis and to understand the clinical presentation,laboratory biochemistry and blood amino acids features of patients with mutations.Methods Blood amino acids were analyzed by using mass chromatography in 115 infants who were referred to our hospital for further investigations of intrahepatic cholestasis from December 2003 to December 2006. All exons and their neighbouring sequences of SLC25A13 gene were analysed in children whose plasma citrulline obviously elevated. Two most common mutations of SLC25A13 gene, 851del4 and 1638ins23 were screened in children without obvious citrullinemia. Mutation 851del4 was detected by real-time fluorescent quantitation PCR with double labelling probes, and mutation 1638ins23 was detected by electrophoresis of PCR product directly. If the children in whom only one heterozygous mutation was found, all exons and nearby sequences were analysed then after. Clinical presentation,laboratory biochemistry and blood amino acids examinations were analyzed.Results SLC25A13 gene mutations were found in 4 of 5 children with citrullinemia, including 1 patient with homozygous mutation 851del4/851del4, 1 patient with compound heterozygous mutation 851del4/1638ins23, and 2 patients with heterozygous mutation 851del4. SLC25A13 gene mutations were also found in 6 cases of the other 110 intrahepatic cholestasis patients, including 1 patient with homozygous mutation 851del4/851del4, 1 patient with compound heterozygous mutation 851del4/1638ins23, and 4 patients with heterozygous mutation 851del4. Totally, SLC25A13 gene mutations were detected in 10 of the 115 intrahepatic cholestasis patients. The prevalence rate was 8.7%. Liver biopsy was done in 7 of 10 children with SLC25A13 gene mutations, and significant steatosis was found in 4 of them. Laboratory biochemistry changes included obviously elevation of bilirubin,γ-glutamyl transpeptidase and alkaline phosphatase. The elevation of aspartate aminotransferase was more obvious than alanine aminotransferase. Characteristic amino acids such as citrulin,threonine and methionine elevation was found in 5 children with mutations.Conclusions SLC25A13 gene mutation was one of the important causes of Chinese infantal intrahepatic cholestasis. Liver biopsy, laboratory biochemistry, and blood amino acids examination were important for the diagnosis of SLC25A13 gene mutations, however, the final diagnosis must rely on gene detection.

Detection of SLC25A13 gene mutation in a family with primary carnitine deficiency and prenatal diagnosis

Detection of SLC22A5 gene mutation in a family with primary carnitine deficiency and prenatal diagnosis

SLC25A13 Gene Mutation Analysis in a Pedigree of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency

Analysis of SLC25A13 Gene Mutations and Prenatal Diagnosis for 20 Families Affected with Citrin Deficiency

[Genetic Analysis of Newborns with Abnormal Metabolism of 3-Hydroxyisovalerylcarnitine].

Identification of a LargeSLC25A13Deletion Via Sophisticated Molecular Analyses Using Peripheral Blood Lymphocytes in an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD): A Clinical and Molecular Study

Molecular Diagnosis of Citrin Deficiency in an Infant with Intrahepatic Cholestasis: Identification of a 21.7kb Gross Deletion That Completely Silences the Transcriptional and Translational Expression of the Affected SLC25A13 Allele.

[Identification and Diagnosis of Three Novel Mutations in SLC25A13 Gene of Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency].

SLC25A13 Cdna Cloning Analysis Using Peripheral Blood Lymphocytes Facilitates the Identification of a Large Deletion Mutation: Molecular Diagnosis of an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency.

Primary carnitine deficiency: Estimation of prevalence in Chinese population and insights into newborn screening

Neonatal Intrahepatic Cholestasis caused by Citrin Deficiency: In vivo and in vitro studies of the aberrant transcription arising from two novel splice-site variants in SLC25A13

Prenatal Diagnosis Of Citrin Deficiency In A Chinese Family With A Fatal Proband

Molecular investigation in Chinese patients with primary carnitine deficiency

[Analysis of clinical and genetic variation in neonatal intrahepatic cholestasis caused by citrin deficiency]

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene

Screening and Short-Term Follow-Up of Newborns and Mothers with Primary Carnitine Deficiency

Cloning and Sequence Analysis of SLC25A13 Transcripts in Human Amniocytes.

Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations.

Clinical, Molecular and Functional Investigation on an Infant with Neonatal Intrahepatic Cholestasis Caused by Citrin Deficiency (NICCD).

[A Novel SLC25A13 Variant and the Resultant Aberrant Transcript Identified in a Pedigree Affected with Citrin Deficiency].

SLC25A13 Gene Mutation in Infants with Intrahepatic Cholestasis